Plasma and CSF benzodiazepine receptor ligand concentrations in cirrhotic patients with hepatic encephalopathy: Relationship to severity of encephalopathy and to pharmaceutical benzodiazepine intake

Metabolic Brain Disease

Volumn 13, Issue 3, 1998, Pages 201-210

  Perney, Pascal ^a   Butterworth, Roger F ^b   Mousseau, Darrell D ^b   Lavoie, Joel ^b   Fabbro Peray, Pascale ^a   Blanc, François ^a   Layrargues, Gilles Pomier ^c  

^a HÔPITAL SAINT ELOI   (France)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

'Endogenous benzodiazepines'; Benzodiazepine receptors; Cirrhosis; Flumazenil; Hepatic Encephalopathy

Indexed keywords

BENZODIAZEPINE RECEPTOR; BROMAZEPAM; CHLORDIAZEPOXIDE; CLONAZEPAM; DIAZEPAM; FLUMAZENIL; FLUNITRAZEPAM; OXAZEPAM;

ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG RECEPTOR BINDING; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; PATHOPHYSIOLOGY; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN LOCALIZATION; RECEPTOR DENSITY;

ANIMALS; BENZODIAZEPINES; BINDING, COMPETITIVE; CELL FRACTIONATION; CEREBELLUM; CHRONIC DISEASE; CLONAZEPAM; DIAZEPAM; FLUMAZENIL; GABA MODULATORS; HEPATIC ENCEPHALOPATHY; HUMANS; ISOQUINOLINES; LIVER CIRRHOSIS; OXAZEPAM; RADIOLIGAND ASSAY; RATS; RECEPTORS, GABA-A; TRITIUM;

EID: 0031759378     PISSN: 08857490     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1023271908568     Document Type: Article

References (25)

1. Antoni M., Botta-Fridlund D., Bourlière M., Bun H. and Gauthier P. (1990). Benzodiazepines and liver diseases: pharmacokinetic and pharmacodynamic study. Gastroenterol. Clin. Biol. 14:492-500.
2. Bansky G., Meier, P.S., Ziegler, W.H., Walser, H., Schmid, H. and Huber, M. (1985). Reversal of hepatic coma by benzodiazepine antagonists (Ro15-1788). Lancet 1:1324-1325.
3. Bansky G., Meier P.J., Riederer, E., Walser H., Ziegler, W.H. and Schmid M. (1989). Effects of the benzodiazepine receptor antagonist flumazenil in hepatic encephalopathy in humans. Gastroenterology 7:744-750.
4. Baraldi M., Zeneroli M., Ventura E., Penne A., Pinelli G., Ricci P. and Santi M. (1984) Supersensitivity of benzodiazepine receptors in hepatic encephalopathy due to fulminant hepatic failure in the rat: reversal by a benzodiazepine antagonist. Clin. Sci. 67:167-175
5. Basile, A.S., Harrison, P.M., Hugues, R.D., Gu Z.Q., Pannell, L., McKinney A. et al. (1994). Relationship between plasma benzodiazepine receptor ligand concentrations and severity of hepatic encephalopathy. Hepatology 19:112-121.
6. Basile A.S., Hugues R.D., Harrison P.M., Murata Y., Pannell L., Jones E.A. and William R. (1991). Elevated brain concentrations of 1-4 benzodiazepines in fulminant hepatic failure. N. Engl. J. Med. 325:473-478.
7. Basile A.S., Jones E.A. and Skolnick P. (1990). The pathogenesis and treatment of hepatic encephalopathy: evidence for the involvement of benzodiazepine receptors ligands. Pharmacol. Rev. 43:27-71.
8. A receptor complex in an experimental model of hepatic encephalopathy: Evidence for elevated levels of an endogenous benzodiazepine receptor ligand. J. Neurochem 53:1057-1063.
9. Bassett, M.L., Mullen K.D., Scholz, B. and Jones, E.A. (1987). Amelioration of hepatic encephalopathy by pharmacologic antagonism of the GABA benzodiazepine receptor comflex in a rabbit model of fulminant hepatic failure. Gastroenterology 93:1069-1077.
10. Butterworth, R.F., Wells, J., and Pomier Layrargues, G. (1995). Detection of benzodiazepines in hepatic encephalopathy: Reply. Hepatology 21:605.
11. 3H]muscimol (GABA-A) binding sites and of central benzodiazepine receptors are unchanged in autopsied brain tissue from cirrhotic patients with hepatic encephalopathy. Hepatology 8:1084-1088.
12. Grimm G., Katzenschlager R., Scheeweiss B., Lenz K., Ferenci P., Madl, C. et al. (1988). Improvement of hepatic encephalopathy treated with flumazenil. Lancet 2:1391-1394.
13. Gyr K., Meier R., Haussler J., Bouletreau P. Fleig W.E., Gatta et al. (1996). Evaluation of the efficacy and safety of flumazenil in the treatment of portal-systemic encephalopathy: a double blind, randomized, placebo controlled multicenter trial. Gut 39:319-324.
14. Klotz U. and Walker S. (1989). Flumazenil and hepatic encephalopathy. Lancet 1:155-156.
15. Lowry O.H., Rosebrough N.S., Farr, A.L. and Randall R.J. (1951). Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:265-275.
16. Meier R., Gyr K. and Scholer A. (1991). Persisting benzodiazepine metabolites responsible for the reaction to the benzodiazepine antagonist flumazenil in patients with hepatic encephalopathy. Gastroenterology 101:274-275.
17. Mullen K.D., Szauter K.M. and Kaminsky-Russ K. (1990). "Endogenous" benzodiazepine activity in body fluids of patients with hepatic encephalopathy. Lancet 336:81-83.
18. Olasmaa M., Rothstein J.D., Guidotti A., Weber R.J., Paul S.M., Spector S. et al. (1990). Endogenous benzodiazepine receptor ligands in human and animal hepatic encephalopathy. J. Neurochem. 55:2015-2023.
19. Pomier Layrargues G., Giguère J.-F., Lavoie J., Perney P., Gagnon S., D'Amour M. et al. (1994). Flumazenil in cirrhotic patients in hepatic coma: a randomized double-blind placebo-controlled crossover trial. Hepatology 19:32-37.
20. Pomier Layrargues G., Giguère J.-F., Lavoie J., Willems B. and Butterworth R.F. (1989). Pharmacokinetics of benzodiazepine antagonist RO 15-1788 in cirrhotic patients with moderate or severe liver dysfunction. Hepatology 10:969-972.
21. Samson Y., Bernuau J., Pappata S., Chavoix C., Baron J.C. and Mazière M.A. (1987). Cerebral uptake of benzodiazepines measured by positron emission tomography in hepatic encephalopathy. N. Engl. J. Med. 316:414-415.
22. Schafer, D.F., Fowler, J.M., Munson, P.J., Thakur, A. Waggoner J.G. and Jones E.A. (1983). Gammaaminobutyric acid and benzodiazepine receptors in an animal model of fulminant hepatic failure. J. Lab. Clin. Med. 102:870-880.
23. Scollo-Lavizzari G. and Steinmann E. (1985). Reversal of hepatic coma by benzodiazepine antagonist (RO 15-1788). Lancet 1:1324.
24. Van der Rijt, C.C.D., Schalm S.W., Meulstree J. and Stignen T.H. (1995). Flumazenil therapy for hepatic encephalopathy: a double-blind cross-over study. Gastroenterol. Clin. Biol. 19:572-580.
25. Zieve L. (1987). Hepatic encephalopathy. In (L. Schiff and E.R. Schiff, eds.) Diseases of the Liver, J.B. Lippincott, Philadelphia, pp. 944-978.